A series of diaryltriazines and diarylpyrimidines are highly potent nonnucleoside reverse transcriptase inhibitors with possible applications as microbicidesVAN HERREWEGE, Yven; VANHAM, Guido; MICHIELS, Jo et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 10, pp 3684-3689, issn 0066-4804, 6 p.Article

Nonnucleoside Reverse Transcriptase Inhibitor Concentrations During Treatment Interruptions and the Emergence of Resistance: A Substudy of the ISS-PART TrialPIRILLO, Maria; PALMISANO, Lucia; VELLA, Stefano et al.AIDS research and human retroviruses. 2010, Vol 26, Num 5, pp 541-545, issn 0889-2229, 5 p.Article

Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitorFERRIS, Robert G; HAZEN, Richard J; SHORT, Steven A et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 10, pp 4046-4051, issn 0066-4804, 6 p.Article

Antiviral Activity of MK-4965, a Novel Nonnucleoside Reverse Transcriptase InhibitorLAI, Ming-Tain; MUNSHI, Vandna; TOUCH, Sinoeun et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 6, pp 2424-2431, issn 0066-4804, 8 p.Article

Reverse Transcriptase Inhibitors as Potential Colorectal MicrobicidesHERRERA, Carolina; CRANAGE, Martin; MCGOWAN, Ian et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 5, pp 1797-1807, issn 0066-4804, 11 p.Article

How common is the non-nucleoside reverse transcriptase inhibitor mutation E138K in clinical practice?BRADSHAW, Daniel; MANDALIA, Sundhiya; NELSON, Mark et al.The Journal of infection. 2011, Vol 63, Num 2, pp 172-173, issn 0163-4453, 2 p.Article

Rapid accumulation of nonnucleoside reverse transcriptase inhibitor-associated resistance : evidence of transmitted resistance in rural South AfricaBARTH, Roos E; WENSING, Annemarie M; TEMPELMAN, Hugo A et al.AIDS (London). 2008, Vol 22, Num 16, pp 2210-2212, issn 0269-9370, 3 p.Article

Reverse transcriptase inhibitors alter uncoupling protein-1 and mitochondrial biogenesis in brown adipocytesRODRIGUEZ DE LA CONCEPCION, M. Luisa; YUBERO, Pilar; DOMINGO, Joan C et al.Antiviral therapy (London). 2005, Vol 10, Num 4, pp 515-526, issn 1359-6535, 12 p.Article

In combination, nucleoside reverse transcriptase inhibitors have significant effects on 3T3-L1 adipocyte lipid accumulation and survivalKOSMISKI, Lisa A; MILLER, Heidi L; KLEMM, Dwight J et al.Antiviral therapy (London). 2006, Vol 11, Num 2, pp 187-195, issn 1359-6535, 9 p.Article

SAMHD1 Specifically Affects the Antiviral Potency of Thymidine Analog HIV Reverse Transcriptase InhibitorsBALLANA, Ester; BADIA, Roger; TERRADAS, Gerard et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 8, pp 4804-4813, issn 0066-4804, 10 p.Article

Topical Nonnucleoside Reverse Transcriptase Inhibitor MC 1220 Partially Prevents Vaginal RT-SHIV Infection of MacaquesSTOLTE-LEEB, Nicole; LODDO, Roberta; STAHL-HENNIG, Christiane et al.AIDS research and human retroviruses. 2011, Vol 27, Num 9, pp 933-943, issn 0889-2229, 11 p.Article

Long term adverse effects related to nucleoside reverse transcriptase inhibitors: Clinical impact of mitochondrial toxicityMAAGAARD, Anne; KVALE, Dag.Scandinavian journal of infectious diseases. 2009, Vol 41, Num 11-12, pp 808-817, issn 0036-5548, 10 p.Article

Exposure of normal and transformed cells to nevirapine, a reverse transcriptase inhibitor, reduces cell growth and promotes differentiationMANGIACASALE, Rosamaria; PITTOGGI, Carmine; LAVIA, Patrizia et al.Oncogene (Basingstoke). 2003, Vol 22, Num 18, pp 2750-2761, issn 0950-9232, 12 p.Article

Pyrimidine deoxynucleoside and nucleoside reverse transcriptase inhibitor metabolism in the perfused heart and isolated mitochondriaMORRIS, Gerald W; LACLAIR, Darcy D; MCKEE, Edward E et al.Antiviral therapy (London). 2010, Vol 15, Num 4, pp 495-505, issn 1359-6535, 11 p.Article

Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitorsAFONSO, Philippe V; MEKAOUCHE, Mourad; HERMINE, Olivier et al.Blood. 2010, Vol 116, Num 19, pp 3802-3808, issn 0006-4971, 7 p.Article

Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitorsHILL, Shawn A; LLOYD, Patricia A; MCDONALD, Shannon et al.The Journal of infectious diseases. 2003, Vol 188, Num 3, pp 424-427, issn 0022-1899, 4 p.Article

Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapyMOORE, Jeff D; ACOSTA, Edward P; JOHNSON, Victoria A et al.Antiviral therapy (London). 2007, Vol 12, Num 6, pp 981-986, issn 1359-6535, 6 p.Article

Capravirine, a nonnucleoside reverse-transcriptase inhibitor in patients infected with HIV-1: A phase 1 studyGEWURZ, Benjamin E; JACOBS, Mark; PROPER, Jo Ann et al.The Journal of infectious diseases. 2004, Vol 190, Num 11, pp 1957-1961, issn 0022-1899, 5 p.Article

Viral Suppression Following Switch to Second-line Antiretroviral Therapy: Associations With Nucleoside Reverse Transcriptase Inhibitor Resistance and Subtherapeutic Drug Concentrations Prior to SwitchJOHNSTON, Victoria; COHEN, Karen; WIESNER, Lubbe et al.The Journal of infectious diseases. 2014, Vol 209, Num 5, pp 711-720, issn 0022-1899, 10 p.Article

In Vitro Cross-Resistance Profile of Nucleoside Reverse Transcriptase Inhibitor (NRTI) BMS-986001 against Known NRTI Resistance MutationsZHUFANG LI; TERRY, Brian; LATAILLADE, Max et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 11, pp 5500-5508, issn 0066-4804, 9 p.Article

Antiviral Activity and In Vitro Mutation Development Pathways of MK-6186, a Novel Nonnucleoside Reverse Transcriptase InhibitorMEIQING LU; FELOCK, Peter J; WILLIAMS, Theresa M et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 6, pp 3324-3335, issn 0066-4804, 12 p.Article

Nucleoside reverse transcriptase inhibitor-sparing regimen (nonnucleoside reverse transcriptase inhibitor+protease inhibitor) was more likely associated with resistance comparing to nonnucleoside reverse transcriptase inhibitor or protease inhibitor + nucleoside reverse transcriptase inhibitor in the randomized ANRS 121 trialSOULIE, Cathia; ASSOUMOU, Lambert; MARCELIN, Anne-Geneviève et al.AIDS (London). 2009, Vol 23, Num 12, pp 1605-1608, issn 0269-9370, 4 p.Article

The risk of developing peripheral neuropathy induced by nucleoside reverse transcriptase inhibitors decreases over time : evidence from the Delta trialARENAS-PINTO, Alejandro; BHASKARAN, Krishnan; DUNN, David et al.Antiviral therapy (London). 2008, Vol 13, Num 2, pp 289-295, issn 1359-6535, 7 p.Article

Correlation weighted successive projections algorithm as a novel method for variable selection in QSAR studies : investigation of anti-HIV activity of HEPT derivativesKOMPANY-ZAREH, Mohsen; AKHLAGHI, Yousef.Journal of chemometrics. 2007, Vol 21, Num 5-6, pp 239-250, issn 0886-9383, 12 p.Article

Non-nucleoside reverse transcriptase inhibitors : a reviewWATERS, L; JOHN, L; NELSON, M et al.International journal of clinical practice (Esher). 2007, Vol 61, Num 1, pp 105-118, issn 1368-5031, 14 p.Article